Epilepsy with eyelid myoclonia

Epilepsy with eyelid myoclonia (EEM), also known as Jeavons syndrome, is a genetic generalized epilepsy syndrome characterized by three hallmark features: eyelid myoclonia (brief, rapid jerking of the eyelids), often accompanied by brief upward deviation of the eyes and sometimes the head; eye closure-induced seizures or EEG abnormalities; and photosensitivity (sensitivity to flickering lights or patterns). The condition primarily affects the central nervous system and typically begins in childhood, usually between the ages of 2 and 14 years, with a peak onset around 6 to 8 years. It affects females more frequently than males. Eyelid myoclonia episodes are very brief (typically lasting 1–6 seconds) and may occur many times per day, often triggered by eye closure in a well-lit environment. Some patients also experience absence seizures and, less commonly, generalized tonic-clonic seizures. The condition is considered a lifelong epilepsy syndrome, as seizures rarely remit completely. The EEG characteristically shows generalized polyspike-and-wave or spike-and-wave discharges, particularly provoked by eye closure and photic stimulation. Cognitive development is usually normal, although the frequent eyelid myoclonia episodes can impact daily activities and quality of life. Treatment involves antiseizure medications, with valproate (valproic acid) being the most commonly used first-line therapy. Other medications that may be effective include levetiracetam, lamotrigine (used cautiously as it may occasionally worsen myoclonic seizures), and ethosuximide for absence seizures. Avoidance of known photic triggers and the use of tinted lenses may also help reduce seizure frequency. Certain antiseizure medications, particularly carbamazepine and phenytoin, should be avoided as they may exacerbate seizures in this syndrome. Despite treatment, complete seizure freedom is difficult to achieve, and most patients require long-term medication management.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Epilepsy with eyelid myoclonia